newsfilter
← Latest News
Earnings Call Transcripts·

ULTRAGENYX CORPORATE UPDATE - ULTRAGENYX PHARMACEUTICAL INC

Good afternoon and welcome to the Ultragenyx Pharmaceutical Conference Call to discuss the U.S. Food and Drug Administration approval of GenGlycos, known as DTX401, for the treatment of glycogen storage disease type 1a o

Company
ULTRAGENYX PHARMACEUTICAL INC
Keywords
ULTRAGENYX PHARMACEUTICAL INC